Riskpilot← Back to searchSign inGet full accessDR AGDESTEIN AS
ASActiveOrg 989251600Åsvegen 59A, 7715 SteinkjerGeneral medical practice activities · NACE 8621Est. 20064 employees
Revenue 2024
NOK 5,6M
-30% vs 2023
EBITDA margin
26.6%
-19% vs 2023
Equity ratio
47.6%
Financial strength
Net profit 2024
NOK 689K
-71% vs 2023
| Revenue | NOK 5,6M | -30% |
| EBITDA | NOK 1,5M | -19% |
| Net profit | NOK 689K | -71% |
| Total assets | NOK 17,9M | -3% |
| Equity | NOK 8,5M | +9% |
| Employees | 4 | — |
Legal name
DR AGDESTEIN AS
Org number
989251600
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
25. januar 2006
Share capital
NOK 100 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Allmenn legetjeneste, herunder eie og forvalte verdipapirer, fast eiendom og andre formuesverdier.
Address
Åsvegen 59A, 7715 Steinkjer
Phone
+4774163380
Email
sjur@sjosialegekontor.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 980 | 8 517 | 8 250 | 8 039 | 5 609 |
| Staff expenses | −1 857 | −1 725 | −2 850 | −2 031 | −1 595 |
| EBITDA | 1 492 | 3 633 | 1 298 | 1 840 | 1 490 |
| Depreciation & amort. | −101 | −103 | −85 | −61 | −60 |
| EBIT | 1 391 | 3 530 | 1 213 | 1 779 | 1 431 |
| Net financials | 1 054 | 5 013 | −198 | −346 | −547 |
| Profit before tax | 2 445 | 8 543 | 1 014 | 1 434 | 884 |
| Tax | 258 | 744 | 222 | −952 | 194 |
| Net profit | 2 187 | 7 799 | 792 | 2 386 | 689 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 18 547 | 20 374 | 17 939 | 18 525 | 17 918 |
| Equity | 5 143 | 10 442 | 11 234 | 7 840 | 8 530 |
| Long-term debt | 7 559 | 5 862 | 5 163 | 9 933 | 9 012 |
| Short-term debt | 5 846 | 4 070 | 1 542 | 752 | 376 |
| Total debt | 13 405 | 9 932 | 6 705 | 10 685 | 9 388 |
EBITDA margin
26.6%
This company
15.8%
Market median
+68% vs market
20202024
Equity ratio
47.6%
This company
38.2%
Market median
+25% vs market
20202024
Return on equity
8.1%
This company
18.4%
Market median
-56% vs market
20202024
Net profit margin
12.3%
This company
8.1%
Market median
+52% vs market
20202024
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20202024
Debt / equity
1.10×
This company
0.62×
Market median
-77% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ER Deputy Member | Deputy Member | 2006 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2006 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DR AGDESTEIN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Elin Rodum Agdestein | Deputy Member | 0 companies |
| Sjur Agdestein | Chairman | 0 companies |